Xenon Pharmaceuticals Inc. (XENE) Insider Trading

Name: Xenon Pharmaceuticals Inc. (XENE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 1, 2026): Thomas Patrick Kelly (Chief Financial Officer): Purchase of 15,000 shares, $559.7K.

Get alerted when insiders trade XENE

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta